• 1
    Aisenberg, A. C.: Studies on delayed hypersensitivity in Hodgkin's disease. J. Clin. Invest. 41: 19651970, 1965.
  • 2
    Bach, F. H.: Measurement of delayed hypersensitivity. In Immunologic Incompetence, B. M.Kagan and E. R.Stiehm, Eds. Chicago, Year Book Medical Publishers, 1971; pp. 137146.
  • 3
    Boyum, A.: Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. 97: 7789, 1968.
  • 4
    David, J. R., Al-Askari, S., Lawrence, H. S., and Thomas, L.: Delayed hypersensitivity in vitro. I. Specificity of inhibition of cell migration by antigen. J. Immunol. 93: 264273, 1966.
  • 5
    Ducos, J., Migueres, J., Colombies, P., Kessous, A., and Poujoulet, N.: Lymphocyte response to PHA in patients with lung cancer. Lancet 1: 11111112, 1970.
  • 6
    Eilber, F. R., and Morton, D. L.: Impaired immunologic reactivity and recurrence following cancer surgery. Cancer 25: 362367, 1970.
  • 7
    Gatti, R. A., and Good, R. A.: Occurrence of malignancy in immunodeficiency diseases—a review. Cancer, 28: 8998, 1971.
  • 8
    Han, T., and Takita, H.: Immunological impairment in bronchogenic carcinoma: a study of lymphocyte response to PHA. Cancer 30: 616620, 1972.
  • 9
    Han, T., and Takita, H.: Studies of correlation of lymphocyte response to PHA with clinical and immunologic status of CLL. Cancer 31: 280285, 1973.
  • 10
    Hartzman, R. J., Bach, M. L., Bach, F. H., Thurman, G. B., and Sell, K. W.: Precipitation of radioactively labeled samples: A semi-automatic multiple sample processor. Cell. Immunol. 4: 182186, 1972.
  • 11
    Hersh, E. M., and Irwin, W. S.: Blastogenic response of lymphocytes from patients with treated and untreated lymphomas. Lymphology 2: 150160, 1969.
  • 12
    Hersh, E. M., Irwin, W. S., Whitecar, J. P., McCredie, K. B., Bodey, G. P., and Freireich, E. J.: Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemia. N. Engl. J. Med. 285: 12111216, 1971.
  • 13
    Hughes L. E., and Mackay, W. D.: Suppression of tuberculin response in malignant disease. Br. Med. J. 2: 13461348, 1965.
  • 14
    Krant, M. J., Manskopf, G., Brandrup, C. S., and Madoff, M. A.: Immunologic alterations in bronchogenic cancer, sequential study. Cancer 21: 623631, 1968.
  • 15
    Lamb, D., Pilney, F., Kelly, W. D., and Good, R. A.: A comparative study of the incidence of anergy in patients with carcinoma, leukemia, Hodgkin's disease and other lymphomas. J. Immunol. 89: 555558, 1962.
  • 16
    Nelson, H. S.: Delayed hypersensitivity in cancer patients: Cutaneous and in vitro lymphocyte response to specific antigens. J. Natl. Cancer Inst. 42: 765770, 1969.
  • 17
    Olsson, C. A., Roa, C. N., Menzoian, J. O., and Byrd, W. E.: Immunologic unreactivity in bladder cancer patients. J. Urol., 107: 607: 609, 1972.
  • 18
    Oppenheim, J. J.: The relationship of in vitro lymphocyte transformation to delayed hypersensitivity in guinea pigs and man. Fed. Proc. 27: 2128, 1968.
  • 19
    Paty, D. W., and Bone, G.: Response to PHA in cancer patients. Lancet 1: 688689, 1973.
  • 20
    Rossio, J. L.: An isopycnic gradient centrifugation procedure for the isolation of immunocompetent lymphocytes from peripheral blood and spleens. M. S. Thesis, Department of Microbiology, The Ohio State University, Columbus, Ohio, 1971.
  • 21
    Scheetz II M. E., Rossio, J. L., and Dodd, M. C.: A sensitive and reproducible assay for the quantitation of the MIF correlate of delayed hypersensitivity in man. Immunol. Commun. 1: 211222, 1972.
  • 22
    Sutherland, R. M., Inch, W. R., and McCredie, J. A.: Phytohemagglutinin (PHA)-induced transformation of lymphocytes from patients with cancer. Cancer 27: 574578, 1971.
  • 23
    Thor, D. E., Jureziz, R. E., Veach, S. R., Miller, E., and Dray, S.: Cell migration inhibition factor released from human peripheral lymphocytes. Nature 219: 755757, 1968.
  • 24
    Watkins, S. M.: The effect of surgery on lymphocyte transformation in patients with cancer. Clin. Exp. Immunol. 14: 6976, 1973.
  • 25
    Whittaker, M. G., Rees, K., and Clark, C. G.: Reduced lymphocyte transformation in breast cancer. Lancet 1: 892893, 1971.
  • 26
    Winer, B. S.: Statistical Principles in Experimental Design. New York, McGraw-Hill, 1971; pp. 855859.